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SHORT COMMUNICATION
Residual Treatment of Aedes aegypti (Diptera: Culicidae) in
Containers Using Pyriproxyfen Slow-Release Granules (Sumilarv 0.5G)
SCOTT A. RITCHIE,1,2 CHRIS PATON,1 TAMARA BUHAGIAR,1 GARRY A. WEBB,3
AND VLADAN JOVIC3
J. Med. Entomol. 50(5): 1169Ð1172 (2013); DOI: http://dx.doi.org/10.1603/ME13043
ABSTRACT The residual efÞcacy of pyriproxyfen against Aedes aegypti (L.) was examined by
treating 2-liter buckets with a range of rates of Sumilarv 0.5G (100, 10, 1, and 0.1 mg product/liter or
nominal dose of 500, 50, 5, and 0.5 ppb active ingredient) under semiÞeld conditions. Approximately
every 2wk, pupal emergence inhibition (EI)wasmeasured by usingCairns colonyAe. aegypti. Pooled
water samples from the Þve replicate buckets were analyzed for active pyriproxyfen by using
ultra-high-pressure liquid chromatographywith tandemmass spectrometry detection. A strong doseÐ
response in EI was exhibited, with the 0.1 mg/liter giving50% EI for only the initial week, whereas
the 10 and 100 mg/liter doses produced EI 90% for 8 and 40 wk, respectively. Measurable levels of
active ingredient were detected in the 100, 10, and 1 mg/liter treatments, with measured starting
concentrations of just 1Ð2Ð1.4% of the delivered (active ingredient) dose. Pyriproxyfen was detected
in the 100 mg/liter treatment through the entire course of the trial (60 wk).
KEY WORDS Aedes aegypti, pyriproxyfen, Sumilarv, doseÐresponse, persistence
In northern Australia, vector control ofÞcers require
residual treatment of containers, as they cannot revisit
properties at 1-mo intervals during large-scale den-
gue control programs. The current Aedes albopictus
(Skuse) eradication program in the Torres Strait of
Australia uses vector control tours at 6Ð8-wk intervals
and requires residual treatment of containers. Todate,
larval control consists of treatment of containers with
s-methoprene pellets or surface spray with residual
synthetic pyrethroid such as bifenthrin. The synthetic
pyrethroids can have nontarget effects and are vul-
nerable to degradation by ultraviolet light outdoors.
High “megadoses” of Bti granules have also been used
to provide residual control (Ritchie et al. 2010).
The insect growth regulator pyriproxyfen has ex-
cellent potential for the residual control ofmosquitoes
such as Aedes aegypti and Ae. albopictus. Pyriproxyfen
works effectively at very low doses (Invest and Lucas
2008,Devine et al. 2009,Webbet al. 2012). In the Þeld,
Sihuincha et al. (2005) obtained 90% control of Ae.
aegypti in water tanks for up to 5 mo by using doses of
just 50Ð83 ppb. Vythilingham et al. (2005) obtained
4Ð5 mo residual control of Ae. aegypti in 50-liter
earthen jars with even lower doses (10Ð20 ppb), and
Chang et al. (2006) suppressed adult emergence from
water storage jars for at least 6 mo by using a resin-
based slow-release formulation of pyriproxyfen.
Useof gravidmosquitoes to “auto-disseminate”min-
ute doses of pyriproxyfen has been developed as a
strategy to control container-breeding mosquitoes
(Itoh et al. 1994, Sihuincha et al. 2005, Devine et al.
2009). Devine et al. (2009) obtained control of Ae.
aegypti by auto-dissemination to adjoining breeding
sites of an estimated dose as small as 0.012 ppb active
ingredient (AI). In North Queensland, Aedes-breed-
ing sites are often small, holding5 liters ofwater, and
the granular formulation of pyriproxyfen (Sumilarv
0.5 G) offers potential not only for control of Ae.
aegypti breeding but also auto-dissemination of active
ingredient from these sentinel breeding sites to ad-
joining untreated sites. In this trial, we measured the
efÞcacy of Sumilarv 0.5 G against Ae. aegypti in small
containers in a semiÞeld cage in Cairns, Queensland,
over a 60-wk period.
Materials and Methods
Impact of Pyriproxyfen Against Ae. aegypti Under
SemifieldConditions.Ae. aegypti larvaewere exposed
to four different doses of pyriproxyfen in 2-liter white
plastic buckets under semiÞeld conditions. Treatment
doses of Sumilarv 0.5Gwere 0.2, 0.02, 0.002, and0.0002
gproduct/2-liter bucket (or 100, 10, 1, 0.1mgproduct/
liter) yielding nominal concentrations of 500, 50, 5,
and 0.5 g (AI)/liter (ppb) of pyriproxyfen, respec-
tively. An untreated bucket served as a control. Five
buckets (one from each treatment group and the con-
trol) were placed inside Þve plastic trays that were set
inside a screened 5 by 7 by 4-m semiÞeld cage to
prevent oviposition from wild Ae. aegypti that might
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confound results, and to protect the buckets from
direct sunlight that could degrade the active ingredi-
ent. The semiÞeld cage was covered with 90% shade
cloth awning that produced a total shadeof 99%.How-
ever, rainfall could penetrate the shade cloth, and
overßowing andwater turnover occurred in the buck-
ets but was not measured. Fortnightly, 20 third-instar
Ae. aegypti (Cairns colony F3Ð10)were added to each
bucket, with 0.5 g of Friskies cat food pellet (NestleÕs
Purina Petcare, Blayney, NSW, Australia) added for
food when needed. Twice each week, pupae were
collected by pipette and placed into 70-ml plastic
jars containing tap water for emergence. For the
highest dose, assessment periods were extended to
4 wk after 30-wk assessment. The trial was run for 60
wk or until control (emergence inhibition or EI)
(The terms control and emergence inhibition may
be used interchangeably) was 50% for a given
treatment.
Meteorological data were obtained for the Cairns
Airport site (10 km SE of the semiÞeld cage) from the
Australian Bureau of Meteorology. The buckets were
exposed to heavy rainfall, with 2,596 ml of rainfall
recorded at the Cairns Airport during the exposure
period. The mean minimum and maximum tempera-
ture during the trial was 20.3 and 28.9C, respectively.
Measurement of Pyriproxyfen in Treatment Buck-
ets. Five 1-ml samples were extracted from each
bucket weekly using a 1-ml pipette from each of the
Þvebuckets. TheÞve samples for each treatmentwere
pooled for subsequent analysis. Water samples were
supplied to ACS Laboratories (Australia) (Kensing-
ton, Victoria) for analysis of pyriproxyfen content in
August 2012. Each sample was diluted 1:1 with ace-
tonitrile and then Þltered through a 0.2-m Teßon
syringe Þlter into a 2-ml glass vial. Two microliters of
the diluted sample was then injected onto a Waters
BEH C18 column (1.7 m, 50 by 2.1 mm) using a
Waters Aquity UPLC-MS-MS (ultra-high-pressure
liquid chromatography with tandem mass spectrom-
etry detection). Pyriproxyfen was eluted with a mix-
ture of acetonitrile and 5 mM trißuoroacetic acid (75:
25) at 0.5 ml/min and quantiÞed by external
calibration. Limit of detection was 0.05 ppb.
Statistical Analysis. An analysis of variance
(ANOVA) was used to compare mean adult emer-
gence between the treatments. The lack of replication
created by pooling the water samples prevented us
from conducting a similar comparison on the pyri-
proxyfen detected in the buckets.
Results
Impact of Pyriproxyfen Against Ae. aegypti Under
Semifield Conditions. A clear doseÐresponse was
noted in the efÞcacy of Sumilarv 0.5G against Ae.
aegypti. The very lowest dose (0.1 mg/liter) provided
50%control for the initialweekbefore rapidly tailing
off. The 10-mg/liter dose gave good control for 8Ð10
wk. The highest dose (100 mg/liter) provided 95%
control for 40wk,with the exception of slightly higher
emergence at 2 and 8 wk (88 and 94% EI, respec-
tively). After 40wk, control gradually declined to 60%
at the conclusion of the trial. An ANOVA was con-
ducted on mean EI for the initial 14 wk of treatment,
afterwhich only the high dosemaintained any level of
control (Fig. 1). There was a signiÞcant interaction
between treatment group and weeks posttreatment
(F(24, 140) 12.41;P 0.0001), aswell as a signiÞcant
effect of “treatment group” (F(4, 140)  269.1; P 
0.0001) and a signiÞcant effect of “weeks posttreat-
ment” (F(6, 140)  39.48; P  0.0001).
DetectionofPyriproxyfen inTreatedWater.Levels
of pyriproxyfen declined steadily in the treated buck-
ets (Table 1) and was dose dependent. After wk 2,
pyriproxyfen was only detected in the highest dose
(100 mg/liter). No active ingredient was detected in
the smallest dose (0.1 mg/liter) at any time, and con-
centrations in water for the 1- and 10-mg/liter doses
fell below the limit of detection after 2 wk and 1 wk
posttreatment, respectively. Pyriproxyfen was de-
tected for 60 wk for the highest treatment dose of 100
mg /liter, but levels in the bucket water rapidly de-
clined to 1 ppb by 12 wk (Fig. 1).
Fig. 1. Mean (SE) pupal emergence ofAe. aegypti in 2-liter buckets treated with varying doses (in milligrams per liter)
of Sumilarv 0.5 G. Trial runs from 11 April 2011 to 6 June 2012.
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Discussion
These data indicate that Sumilarv granules can pro-
vide persistent control of Ae. aegypti under simulated
Þeld conditions. Both control and detection of (AI) in
water samples were strongly dose dependent. The
minimum dose, 0.1 mg/liter (or the equivalent of a
single Sumilarv granule/bucket), even provided brief
control for 2 wk, with increasing levels of control and
residuality for the higher doses. The highest dose (100
mg/liter) provided85% control for the entire study
and95% for all but two sample periods (88 and 94%
at wk 2 and 8, respectively). High doses of Sumilarv
could be used to provide very long residual control of
Aedes in typical small breeding sites such as water
storage containers, tires, sump pits, and other small
water reservoirs thatmight serve as breeding sites.We
acknowledge that the exposure of treated bucketswas
conducted under semiÞeld conditions that may not
reßect conditions in the Þeld, particularly exposure to
ultraviolet light, detritus, and rainfall. Additional stud-
ies of pyriproxyfen persistence should be conducted
under a range of Þeld conditions.
The persistence of active pyriproxyfen within
treated buckets shows that active ingredient is slowly
released into the water. The initial highest dose (100
mg/liter) was sufÞcient to create a concentration of
500 ppb of pyriproxyfen. However, we detected a
concentration of only 7.5 ppb at wk 1, just 1.4% of the
total (AI)dose.Thiswasconsistent for the lowerdoses
too, with residual pyriproxyfen detected in water at
wk 1 representing just 1.2 and 1.4% of the total doses
applied for the 50 and 5 ppb treatments, respectively.
Webb et al. (2011) reported initial levels of pyriproxy-
fen in water of 7 ppb, after application of a liquid
formulation at a nominal rate of just 7 ppb, and this
declined to 1 ppb within 5Ð7 d. In liquid form, the
pyriproxyfen is freely available in solution initially,
whereas the granular application releases only small
amounts of pyriproxyfen over a longer period, making
it more suitable for long-term residual control. A lim-
itationof the study is that a single pooledwater sample
was used for analysis, effectively eliminating any rep-
lication.
Temporary control in breeding sites, even using
very low doses for short periods, could be used to
reduce wild populations of Ae. aegypti to enhance
establishment of Wolbachia in open-Þeld releases
(Hancock et al. 2011, Hoffmann et al. 2011). Field
workers have used bleach to provide short-term con-
trol of Ae. aegypti in breeding sites as part of a “crash
and release” strategy (Jacups et al. 2013). However,
the auto-dissemination of pyriproxyfen, either as a
dust or dissolved in water, could be used to treat
cryptic and inaccessible breeding sites such as septic
tanks and roof gutters. Contaminated mosquitoes
could be used to transfer effective doses of pyriproxy-
fen to such sites (Devine et al. 2009,Caputo et al. 2012,
Gaugler et al. 2012). Devine et al. (2009) demon-
strated that adultAe. aegypticouldbecaptured in traps
where they pick up minute dust particles containing
pyriproxyfen that are then disseminated to breeding
sites by the mosquito. The dose data from Table 1
could also be used to estimate longevity of control
based on the dose of pyriproxyfen and amount of (AI)
in the water. This could be useful for estimating the
timing of auto-dissemination treatment and release of
Wolbachia-infected mosquitoes to avoid killing off-
spring of released mosquitoes.
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